🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert Walker

Royal Surrey NHS Foundation Trust

ORCID: 0000-0003-2101-1318

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts”.

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100541

N/A

0DataRank · unranked

24 citations

Annette Hayden, Antigoni Manousopoulou, Andrew Cowie, Robert Walker, Jack Harrington +20 more

The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes

NAR Cancer(2023)10.1093/narcan/zcad040

N/A

0DataRank · unranked

6 citations

Jane Hc Loong, Jan Attig, George R. Young, Piyali Ganguli, Ginny Devonshire +76 more

Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation

Molecular & Cellular Proteomics(2024)10.1016/j.mcpro.2024.100764

N/A

0DataRank · unranked

12 citations

Marcos Yébenes Mayordomo, Goran Mitulović, Sofian Al Shboul, Georges Bedran, Jakub Faktor +82 more